Probiotic effects of orally administered Lactobacillus salivarius WB21-containing tablets on periodontopathic bacteria: a double-blinded, placebo-controlled, randomized clinical trial. (Q46005687)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Probiotic effects of orally administered Lactobacillus salivarius WB21-containing tablets on periodontopathic bacteria: a double-blinded, placebo-controlled, randomized clinical trial. |
scientific article |
Statements
1 reference
Probiotic effects of orally administered Lactobacillus salivarius WB21-containing tablets on periodontopathic bacteria: a double-blinded, placebo-controlled, randomized clinical trial. (English)
1 reference
Lactobacillus salivarius
1 reference
1 reference
Yoshimi Benno
1 reference
Gen Mayanagi
1 reference
Moto Kimura
1 reference
Seigo Nakaya
1 reference
Haruhisa Hirata
1 reference
Hidetoshi Shimauchi
1 reference
22 April 2009
1 reference
36
1 reference
6
1 reference
506-513
1 reference
1 reference
1 reference